Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages

European Journal of Nutrition

Volumn 50, Issue 5, 2011, Pages 323-330

  Coleman, Sara L ^a   Park, Young Ki ^a   Lee, Ji Young ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adipocyte fatty acid binding protein; Cyclooxygenase 2; Fatty acids; Histone deacetylase; RAW 264.7 macrophages

Indexed keywords

FATTY ACID BINDING PROTEIN 4; HISTONE; HISTONE DEACETYLASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LIPOPOLYSACCHARIDE; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; PROSTAGLANDIN SYNTHASE; RNA; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UNSATURATED FATTY ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEACETYLATION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASE INHIBITORS; HISTONES; HYDROXAMIC ACIDS; INFLAMMATION; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 79955381879     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-010-0140-9     Document Type: Article

References (51)

1. Hertzel AV, Bernlohr DA (2000) The mammalian fatty acidbinding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 11:175-180 (Pubitemid 30457137)
2. Boord JB, Fazio S, Linton MF (2002) Cytoplasmic fatty acidbinding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13:141-147 (Pubitemid 34280765)
3. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22:1686-1691
4. Makowski L, Hotamisligil GS (2004) Fatty acid binding proteins- the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 134:2464S-2468S (Pubitemid 39201622)
5. Cook KS, Hunt CR, Spiegelman BM (1985) Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control. J Cell Biol 100:514-520 (Pubitemid 15173257)
6. Bernlohr DA, Bolanowski MA, Kelly TJ Jr, Lane MD (1985) Evidence for an increase in transcription of specific mRNAs during differentiation of 3T3-L1 preadipocytes. J Biol Chem 260:5563-5567 (Pubitemid 15008113)
7. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379 (Pubitemid 26391462)
8. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141:3388-3396 (Pubitemid 32269028)
9. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, Minokoshi Y, Kahn BB, Parker RA, Hotamisligil GS (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107-119 (Pubitemid 43960591)
10. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705 (Pubitemid 32588026)
11. Layne MD, Patel A, Chen YH, Rebel VI, Carvajal IM, Pellacani A, Ith B, Zhao D, Schreiber BM, Yet SF, Lee ME, Storch J, Perrella MA (2001) Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 15:2733-2735
12. Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 27:1796-1802 (Pubitemid 47207176)
13. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447:959-965 (Pubitemid 46975747)
14. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS (2006) A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA 103:6970-6975
15. Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil GS, Thorne A, Ryden M, Hamsten A, Arner P (2001) Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44:1268-1273 (Pubitemid 33010503)
16. Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36:621-625 (Pubitemid 44213828)
17. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405-413
18. Cabre A, Lazaro I, Girona J, Manzanares JM, Marimon F, Plana N, Heras M, Masana L (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195:e150-e158 (Pubitemid 47569987)
19. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115:1537-1543 (Pubitemid 46648638)
20. Bagheri R, Qasim AN, Mehta NN, Terembula K, Kapoor S, Braunstein S, Schutta M, Iqbal N, Lehrke M, Reilly MP (2010) Relation of plasma Fatty Acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am J Cardiol 106:1118-1123
21. Helledie T, Antonius M, Sorensen RV, Hertzel AV, Bernlohr DA, Kolvraa S, Kristiansen K, Mandrup S (2000) Lipid-binding proteins modulate ligand-dependent trans-activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res 41:1740-1751
22. Makowski L, Hotamisligil GS (2005) The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr Opin Lipidol 16:543-548 (Pubitemid 41376904)
23. Wang S, Wu D, Lamon-Fava S, Matthan NR, Honda KL, Lichtenstein AH (2009) In vitro fatty acid enrichment of macrophages alters inflammatory response and net cholesterol accumulation. Br J Nutr 102:497-501
24. Chang CS, Sun HL, Lii CK, Chen HW, Chen PY, Liu KL (2010) Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide- induced RAW 264.7 macrophages. Inflammation 33:46-57
25. Park YK, Rasmussen HE, Ehler SJ, Blobaum KR, Lu F, Schlegel VL, Carr TP, Lee JY (2008) Repression of proinflammatory gene expression by lipid extract of Nostoc commune var sphaeroides Kutzing, a blue-green alga, via inhibition of nuclear factor-kappa B in RAW 264.7 macrophages. Nutr Res 28:83-92
26. Rasmussen HE, Blobaum KR, Park YK, Ehlers SJ, Lu F, Lee JY (2008) Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element binding proteins in HepG2 cells. Nutr J 138:476-481 (Pubitemid 351355243)
27. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR (2005) Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 25:1220-1224 (Pubitemid 40776612)
28. Pelton PD, Zhou L, Demarest KT, Burris TP (1999) PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun 261:456-458 (Pubitemid 29392497)
29. Hu E, Kim JB, Sarraf P, Bruce M, Spiegelman N (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100-2103 (Pubitemid 27020707)
30. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK (1997) Transcriptional activation by peroxisome proliferatoractivated receptor gamma Is Inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132 (Pubitemid 27090069)
31. Camp HS, Tafuri SR, Leff T (1999) C-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptorgamma 1 and negatively regulates its transcriptional activity. Endocrinology 140:392-397 (Pubitemid 29011184)
32. Necela BM, Su W, Thompson EA (2008) Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages. Immunology 125:344-358
33. Distel RJ, Ro HS, Rosen BS, Groves DL, Spiegelman BM (1987) Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos. Cell 49:835-844
34. Rauscher FJ 3rd, Sambucetti LC, Curran T, Distel RJ, Spiegelman BM (1988) Common DNA binding site for fos protein complexes and transcription factor AP-1. Cell 52:471-480
35. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ, Lane MD (1989) Differentiation- induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 3:1323-1335
36. Herrera R, Ro HS, Robinson GS, Xanthopoulos KG, Spiegelman BM (1989) A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Mol Cell Biol 9:5331-5339 (Pubitemid 20004349)
37. Hui X, Li H, Zhou Z, Lam KSL, Xiao Y, Wu D, Ding K, Wang Y, Vanhoutte PM, Xu A (2010) Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem 285:10273-10280
38. Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM (2001) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 61:8492-8497 (Pubitemid 33131130)
39. Della Ragione F, Criniti V, Della Pietra V, Borriello A, Oliva A, Indaco S, Yamamoto T, Zappia V (2001) Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett 499:199-204 (Pubitemid 32553864)
40. Mariadason JM, Corner GA, Augenlicht LH (2000) Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60:4561-4572 (Pubitemid 32103641)
41. Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5:245-253
42. Zhang J, Kalkum M, Chait BT, Roeder RG (2002) The N-CoRHDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9:611-623 (Pubitemid 34273791)
43. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526 (Pubitemid 38264429)
44. Lee SK, Kim JH, Lee YC, Cheong J, Lee JW (2000) Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein- 1, nuclear factor-kappaB, and serum response factor. J Biol Chem 275:12470-12474 (Pubitemid 30241389)
45. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and betaamyloid precursor protein. Cell 110:55-67 (Pubitemid 34874606)
46. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG, Glass CK (2003) Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression. Mol Cell Biol 23:5780-5789 (Pubitemid 36951340)
47. Herschman HR (1996) Prostaglandin synthase 2. Biochim Biophys Acta 1299:125-140 (Pubitemid 26007741)
48. Schonbeck U, Sukhova GK, Graber P, Coulter S, Libby P (1999) Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155:1281-1291 (Pubitemid 29488935)
49. Belton OA, Duffy A, Toomey S, Fitzgerald DJ (2003) Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 108:3017-3023 (Pubitemid 37553572)
50. McGettigan P, Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296:1633-1644 (Pubitemid 44511610)
51. Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J (2006) Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 114:1028-1035 (Pubitemid 44358879)